Boston Scientific Corp/ US1011371077 /
| 2024-04-26 9:59:59 PM | Chg. -0.16 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 73.12USD | -0.22% | 289,614 Turnover: 21.22 mill. |
-Bid Size: - | -Ask Size: - | 107.35 bill.USD | - | 67.75 |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,490 | 1,630 | 1,697 | 1,782 | 2,079 | ||||||
| Intangible Assets | 6,194 | 5,883 | 5,837 | 6,372 | 7,886 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 14,662 | 14,857 | 15,220 | 16,996 | 25,866 | ||||||
| Inventories | 1,016 | 955 | 1,078 | 1,166 | 1,579 | ||||||
| Accounts Receivable | 1,275 | 1,472 | 1,548 | 1,608 | 1,828 | ||||||
| Cash and Cash Equivalents | 319 | 196 | 188 | 146 | 217 | ||||||
| Current Assets | 3,471 | 3,239 | 3,822 | 4,003 | 4,699 | ||||||
| Total Assets | 18,133 | 18,096 | 19,042 | 20,999 | 30,565 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 209 | 447 | 530 | 349 | 542 | ||||||
| Long-term debt | 5,674 | 5,420 | 3,815 | 4,803 | 8,592 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 735 | 18 | 191 | 328 | 595 | ||||||
| Liabilities | 11,813 | 11,363 | 12,030 | 12,273 | 16,688 | ||||||
| Share Capital | 16 | 16 | 16 | 16 | 16 | ||||||
| Total Equity | 6,320 | 6,733 | 7,012 | 8,726 | 13,877 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 18,133 | 18,096 | 19,042 | 20,999 | 30,565 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,477 | 8,386 | 9,048 | 9,823 | 10,735 | ||||||
| Depreciation (total) | 495 | 545 | 565 | 599 | 699 | ||||||
| Operating Result | -327 | 447 | 1,285 | 1,506 | 1,518 | ||||||
| Interest Income | -284 | -233 | -229 | -241 | -473 | ||||||
| Income Before Taxes | -650 | 177 | 933 | 1,422 | 687 | ||||||
| Income Taxes | -411 | -170 | 828 | -249 | -4,013 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -239 | 347 | 104 | 1,671 | 4,700 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 600 | 972 | 1,426 | 310 | 1,836 | ||||||
| Cash Flow from Investing Activities | -2,186 | -887 | -1,010 | -1,921 | -5,041 | ||||||
| Cash Flow from Financing | 1,322 | -206 | 110 | 1,432 | 2,973 | ||||||
| Decrease / Increase in Cash | -268 | -123 | 530 | -188 | -222 | ||||||
| Employees | 25,000 | 27,000 | 29,000 | 32,000 | 36,000 | ||||||
